Abstract
Background:
Atrial fibrosis was considered a structural basis for the development and sustaining of atrial fibrillation (AF). Transforming growth factor‐β1 (TGF‐β1) was one of the main factors for accelerating collagen production. The contribution of TGF‐β1 in the pathogenesis of AF needs further investigation.
Hypothesis:
The altered expression and distribution of TGF‐β1 will be associated with the changes in atrial fibrosis in different types of AF patients with rheumatic heart disease (RHD).
Methods:
Right atrial specimens obtained from 38 RHD patients undergoing mitral valve replacement surgery were divided into 3 groups: the sinus rhythm group (n = 8), the paroxysmal AF group (pAF; n = 10), and the chronic AF group (cAF; AF lasting ≥ 6 mo; n = 20). The degree of atrial fibrosis, collagen content, serum levels, messenger RNA (mRNA), and protein expression of TGF‐β1 were detected.
Results:
The collagen content, serum level, TGF‐β1 mRNA, and protein expression of the atrial tissue increased gradually in sinus rhythm, for both pAF and cAF groups, respectively. A positive correlation between TGF‐β1 and the degree of atrial fibrosis was also demonstrated (P < 0.05).
Conclusion:
The TGF‐β1 expression in atrial tissue increased gradually in proportion to the degree of atrial fibrosis in AF and was associated with the type of AF, which suggests that TGF‐β1 is possibly involved in the pathogenesis of AF in RHD patients. Copyright © 2010 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (2.1 MB).
References
- 1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415(6868): 219–226. [DOI] [PubMed] [Google Scholar]
- 2. Nattel S, Shiroshita‐Takeshita A, Cardin S, et al. Mechanisms of atrial remodeling and clinical relevance. Curr Opin Cardiol 2005; 20(1): 21–25. [PubMed] [Google Scholar]
- 3. Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007; 4(3 Suppl): 24–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci 2008; 65(10): 1489–1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002; 54(2): 361–379. [DOI] [PubMed] [Google Scholar]
- 6. Li X, Ma C, Dong J, et al. The fibrosis and atrial fibrillation: is the transforming growth factor‐β1 a candidate etiology of atrial fibrillation. Med Hypotheses 2008; 70(2): 317–319. [DOI] [PubMed] [Google Scholar]
- 7. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor‐β in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006; 118(1): 10–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96(4): 1180–1184. [DOI] [PubMed] [Google Scholar]
- 9. Boldt A, Wetzel U, Lauschke J, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004; 90(4): 400–405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Mariscalco G, Engstrom KG, Ferrarese S, et al. Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg 2006; 131(6): 1364–1372. [DOI] [PubMed] [Google Scholar]
- 11. Nakai T, Chandy J, Nakai K, et al. Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology 2007; 108(2): 90–96. [DOI] [PubMed] [Google Scholar]
- 12. Polyakova V, Miyagawa S, Szalay Z, et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 2008; 12(1): 189–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004; 109(3): 363–368. [DOI] [PubMed] [Google Scholar]
- 14. Lijnen P, Petrov V. Transforming growth factor‐β1‐induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol 2002; 24(6): 333–344. [DOI] [PubMed] [Google Scholar]
- 15. Davidson JM, Zoia O, Liu JM. Modulation of transforming growth factor‐β1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor‐alpha, and insulin‐like growth factor‐I. J Cell Physiol 1993; 155(1): 149–156. [DOI] [PubMed] [Google Scholar]
- 16. Wu XY, Yang YM, Guo H, et al. The role of connective tissue growth factor, transforming growth factor β1 and SMAD signaling pathway in cornea wound healing. Chin Med J (Engl) 2006; 119(1): 57–62. [PubMed] [Google Scholar]
- 17. Bujak M, Frangogiannis NG. The role of TGF‐β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007; 74(2): 184–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Huang J, Qin GH, Hu CX, et al. Effects of transforming growth factor‐β1 and signal protein SMAD3 on rat cardiomyocyte hypertrophy. Chin Med J (Engl) 2004; 117(10): 1471–1475. [PubMed] [Google Scholar]
- 19. Nakajima H, Nakajima HO, Salcher O, et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor‐β (1) transgene in the heart. Circ Res 2000; 86(5): 571–579. [DOI] [PubMed] [Google Scholar]
- 20. Rosenkranz S, Flesch M, Amann K, et al. Alterations of β‐adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF‐β(1). Am J Physiol Heart Circ Physiol 2002; 283(3): H1253–H1262. [DOI] [PubMed] [Google Scholar]
- 21. Verheule S, Sato T, Everett T, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF‐β1. Circ Res 2004; 94(11): 1458–1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. On YK, Jeon ES, Lee SY, et al. Plasma transforming growth factor β1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. J Thorac Cardiovasc Surg 2009; 137(6): 1515–1520. [DOI] [PubMed] [Google Scholar]
- 23. Gramley F, Lorenzen J, Koellensperger E, et al. Atrial fibrosis and atrial fibrillation: the role of the TGF‐β (1) signaling pathway. Int J Cardiol 2009. [DOI] [PubMed] [Google Scholar]